First Patient Screened for the European Product Candidate Estelle® (E4/DRSP) Phase III Clinical Study: the Phase III Has Started in Europe Ahead of Schedule

Liège, Belgium 30 June 2016 – Mithra announces today that the first patient has been screened for enrolment in the European Phase III clinical trials for its Estetrol-based product candidate Estelle® (E4/DRSP). The screening of this first patient marks the launch of the Estelle® (E4/DRSP) Phase III clinical trial in Europe.

Read the press release